PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
234.00
-10.00 (-4.10%)
Jun 22, 2026, 11:46 AM WIB

IDX:DGNS Balance Sheet

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6,1138,4754,20910,24528,01144,720
Short-Term Investments
1,4581,458959.591,6962,5436,507
Cash & Short-Term Investments
7,5719,9335,16911,94130,55351,227
Cash Growth
19.39%92.17%-56.71%-60.92%-40.36%209.75%
Accounts Receivable
44,43546,27641,81038,28042,42241,730
Other Receivables
8,21510,4277,0796,9727,03332,209
Receivables
52,65056,70348,88945,25249,45573,939
Inventory
7,1686,0795,0435,1426,5677,760
Prepaid Expenses
235.56357.75275.79194.89266.08784.92
Other Current Assets
25,88418,12519,23125,27531,53220,153
Total Current Assets
93,50991,19878,60887,805118,373153,864
Property, Plant & Equipment
207,149209,420202,426164,248109,21987,107
Long-Term Investments
12,95112,95112,95112,9518,445-
Other Intangible Assets
1,6891,6701,353720.43681.12-
Long-Term Deferred Tax Assets
697.72697.72815.571,0311,0201,012
Other Long-Term Assets
2,7362,7363,8694,7192,198-
Total Assets
318,731318,672300,022271,475239,936241,983
Accounts Payable
12,9158,9219,5516,0903,0784,524
Accrued Expenses
4,8366,4464,1163,1781,5563,125
Current Portion of Long-Term Debt
6,2512,612152.08-1,701-
Current Portion of Leases
4,4364,3945,0123,7101,8112,390
Current Income Taxes Payable
646.1153.71255.12268.87674.8316,013
Current Unearned Revenue
2,9564,7781,748651.53893.77-
Other Current Liabilities
288.63310.34772.59545.72777.24576.26
Total Current Liabilities
32,33027,61521,60614,44410,49226,628
Long-Term Debt
49,35049,50844,81730,0009,358-
Long-Term Leases
18,05120,63220,40121,004409.042,888
Long-Term Unearned Revenue
6,5456,8007,820---
Pension & Post-Retirement Benefits
1,6381,5481,2922,1561,6863,103
Other Long-Term Liabilities
8,1438,5787,9548,2807,5637,563
Total Liabilities
116,057114,682103,89075,88529,50840,182
Common Stock
31,25031,25031,25031,25031,25031,250
Additional Paid-In Capital
36,70736,70736,70736,70736,70736,707
Retained Earnings
133,886135,202132,265131,518145,173132,509
Comprehensive Income & Other
831.26831.26-4,090-3,884-2,7021,335
Shareholders' Equity
202,674203,990196,132195,590210,428201,800
Total Liabilities & Equity
318,731318,672300,022271,475239,936241,983
Total Debt
78,08877,14670,38254,71413,2795,277
Net Cash (Debt)
-70,517-67,214-65,213-42,77317,27445,950
Net Cash Growth
-----62.41%229.33%
Net Cash Per Share
-56.41-53.77-52.17-34.2213.8237.04
Filing Date Shares Outstanding
1,2501,2501,2501,2501,2501,250
Total Common Shares Outstanding
1,2501,2501,2501,2501,2501,250
Working Capital
61,17963,58257,00273,361107,881127,236
Book Value Per Share
162.14163.19156.91156.47168.34161.44
Tangible Book Value
200,985202,320194,779194,870209,747201,800
Tangible Book Value Per Share
160.79161.86155.82155.90167.80161.44
Land
60,80260,80254,64343,65543,65543,655
Buildings
82,77382,773----
Machinery
48,89648,58646,44744,28539,54831,771
Construction In Progress
13,88513,62788,00153,06118,411311.4
Leasehold Improvements
27,72127,72127,85726,02623,67214,201